Kolexia
Figarella-Branger Dominique
Anatomie et cytologie
Hôpital La Timone
Marseille, France
443 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du cerveau Gliome Glioblastome Tumeurs du système nerveux central Oligodendrogliome Astrocytome Méningiome Médulloblastome Récidive tumorale locale

Industries

MSD
1 collaboration(s)
Dernière en 2021
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

MM-Predict: Prospective Cohort of Patients With Newly Diagnosed Glioblastoma: Analysis of MMP2 and MMP9 Expression and Correlation to Neuro-imaging Features.
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   04 mars 2024
SIOP-PNET-4: A Prospective Randomised Controlled Trial of Hyperfractionated Versus Conventionally Fractionated Radiotherapy in Standard Risk Medulloblastoma
Essai Clinique (Institut Curie)   29 janvier 2024
Classification moléculaire de 83 glioblastomes cérébelleux français et identification de sous-groupes pronostiques
Congrès AM/CHEC 2023   01 décembre 2023
Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline.
Neuro-oncology   05 octobre 2023
P02.09.A THE PLASTICITY AND SURVIVAL OF GLIOBLASTOMA STEM CELLS DEPEND ON GD3, WHOSE INHIBITION IS SYNERGISTIC WITH RADIO-CHEMOTHERAPY
Abstracts from the 18th Meeting of the European Association of Neuro-Oncology   08 septembre 2023
P12.09.B SMAC MIMETICS REPROGRAMS GLIOBLASTOMA IMMUNE LANDSCAPE AND POLARIZES MICROGLIA TOWARD A PRO-INFLAMMATORY ANTI-TUMORAL PHENOTYPE
Abstracts from the 18th Meeting of the European Association of Neuro-Oncology   08 septembre 2023
KS02.5.A OVERALL SURVIVAL ASSOCIATED WITH FIRST-LINE PCV OR TEMOZOLOMIDE IN COMBINATION WITH RADIOTHERAPY IN PATIENTS WITH IDH-MUTANT, 1P/19Q CODELETED, GRADE 3 OLIGODENDROGLIOMA: ANALYSIS FROM THE POLA COHORT
Abstracts from the 18th Meeting of the European Association of Neuro-Oncology   08 septembre 2023
Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms.
EBioMedicine   10 août 2023
Deciphering the Action of Neuraminidase in Glioblastoma Models.
International journal of molecular sciences   19 juillet 2023
MelBase: Constitution of a National Cohort of Patients With Metastatic Melanoma Resectable Stage II or Stage III or IV or Unresectable Primary With the Objective of Setting up Epidemiological Monitoring and Clinico-biological Database, MELBASE
Essai Clinique (Assistance publique – Hôpitaux de Paris)   07 juillet 2023